المؤلفون: Valk, G. D.^Aff6, van Leeuwaarde, R. S.^Aff6, van Treijen, M. J. C.^Aff7, Links, T. P.^Aff8, Peeters, R. P.^Aff9, Timmers, H. J. L. M.^Aff10, van der Kleij-Corssmit, E. P. M.^Aff11, Dekkers, O. M.^Aff12, Feelders, R. A.^Aff13, Haak, H. R.^Aff14, Biermasz, N. R.^Aff11, Hofland, J.^Aff13, de Herder, W. W.^Aff13, Pereira Arias, A. M.^Aff15, Lips, P. T. A. M.^Aff16, Smit, J. W. A.^Aff17, Lips, C. J. M.^Aff18, Kapiteijn, H. W.^Aff19, Kievit, J.^Aff20, ten Kroode, H. F.^Aff21

المساهمون: van Krieken, J.H.J.M., editor^Aff1, Beets-Tan, R.G.H., editor^Aff2, Gelderblom, A.J., editor^Aff3, Olofsen, M.J.J., editor^Aff4, Rutten, H.J.T., editor^Aff5

المصدر: Leerboek oncologie. :533-583

المؤلفون: Bergman, W.^Aff5, van Dijk, M. R.^Aff6, van Doorn, R.^Aff7, Kapiteijn, H. W.^Aff8, de Wilt, J. H. W.^Aff9

المساهمون: van de Velde, C.J.H., editor^Aff1, van der Graaf, W.T.A., editor^Aff2, van Krieken, J.H.J.M., editor^Aff3, Marijnen, C.A.M., editor^Aff4

المصدر: Leerboek oncologie. :403-418

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: van der Hiel, Bernies, Haanen, John B A G, Stokkel, Marcel P M, Peeper, Daniel S., Jimenez, Connie R., Beijnen, Jos H, van de Wiel, Bart A., Boellaard, Ronald, van den Eertwegh, Alfons J M, van Tinteren, H., Wessels, Lodewyk F A, Lolkema, Martijn P J K, Hoekstra, Otto S, Hospers, Geke A P, Brouwers, Adrienne H, Koornstra, R.H.T., Arens, A. I. J., de Vos, F. Y.F.L., Hobbelink, M. G.G., Kapiteijn, H. W., de Geus-Oei, L. F., Kruit, W. H.J., Verzijlbergen, F.J., Aarts, M. J.B., Mottaghy, F. M., de Groot, J. W.B., Knollema, S., Piersma, D., Agool, A., Vreugdenhil, Art, Liem, I H, van den Berkmortel, Franchette W P J, Schreurs, M.W.

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), AGEM - Re-generation and cancer of the digestive system, Medical oncology laboratory, CCA - Cancer Treatment and quality of life, Medical oncology

المصدر: BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)
BMC Cancer
BMC Cancer, 17:649. BMC
van der Hiel, B, Haanen, J B A G, Stokkel, M P M, Peeper, D S, Jimenez, C R, Beijnen, J H, van de Wiel, B A, Boellaard, R, van den Eertwegh, A J M & REPOSIT study group 2017, ' Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma : response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study ', BMC Cancer, vol. 17, no. 1, pp. 649 . https://doi.org/10.1186/s12885-017-3626-5
BMC Cancer, 17(1). BioMed Central

مصطلحات موضوعية: 0301 basic medicine, Oncology, Pathology, Cancer Research, Indoles, Skin Neoplasms, medicine.medical_treatment, Resistance, Targeted therapy, BRAF-MUTATED MELANOMA, chemistry.chemical_compound, Study Protocol, 0302 clinical medicine, Piperidines, Antineoplastic Combined Chemotherapy Protocols, Medicine, METASTATIC MELANOMA, Multicenter Studies as Topic, Vemurafenib, Stage IIIc/IV melanoma, Melanoma, IN-VIVO, Sulfonamides, medicine.diagnostic_test, IMPROVED SURVIVAL, MEK inhibitor, RANDOMIZED CONTROLLED-TRIAL, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Treatment Outcome, Positron emission tomography, Research Design, 030220 oncology & carcinogenesis, medicine.drug, F-FLT, BRAF inhibitor, medicine.medical_specialty, PET/CT, CELL LUNG-CANCER, F-FDG, lcsh:RC254-282, Disease-Free Survival, F-18-FDG, 03 medical and health sciences, Clinical Trials, Phase II as Topic, Internal medicine, Genetics, Journal Article, Humans, Stage IIIC, F-18-FLT, MEK INHIBITION, LYMPH-NODE, Neoplasm Staging, Cobimetinib, PET-CT, business.industry, MUTATIONS, medicine.disease, MUTANT MELANOMA, 18F-FDG, 030104 developmental biology, chemistry, Drug Resistance, Neoplasm, Positron-Emission Tomography, 18F-FLT, Azetidines, business

وصف الملف: application/pdf; image/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c02d653c3daf088c7e80efb77f3045c1
https://doi.org/10.1186/s12885-017-3626-5

المؤلفون: van der Hiel, Bernies, Haanen, John B A G, Stokkel, Marcel P M, Peeper, Daniel S., Jimenez, Connie R., Beijnen, Jos H, van de Wiel, Bart A., Boellaard, Ronald, van den Eertwegh, Alfons J M, van Tinteren, H., Wessels, Lodewyk F A, Lolkema, Martijn P J K, Hoekstra, Otto S, Hospers, Geke A P, Brouwers, Adrienne H, Koornstra, R.H.T., Arens, A. I. J., de Vos, F. Y.F.L., Hobbelink, M. G.G., Kapiteijn, H. W., de Geus-Oei, L. F., Kruit, W. H.J., Verzijlbergen, F.J., Aarts, M. J.B., Mottaghy, F. M., de Groot, J. W.B., Knollema, S., Piersma, D., Agool, A., Vreugdenhil, Art, Liem, I H, van den Berkmortel, Franchette W P J, Schreurs, M.W., REPOSIT study group

مصطلحات موضوعية: F-FLT, BRAF inhibitor, MEK inhibitor, Cancer Research, Oncology, PET/CT, Resistance, F-FDG, Genetics, Journal Article, Stage IIIc/IV melanoma

وصف الملف: image/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_____10691::2a2e802578153f7317e5c38498c25f10
https://dspace.library.uu.nl/handle/1874/356417

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.